Atom Investors’s Precigen PGEN Stock Holding History

Atom Investors’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-61,825	Closed	-$258K	–	796
2025 Q4	$258K	Buy	61,825 +46,996	+317%	+$182K	0.02%	463
2025 Q3	$48.8K	Buy	+14,829	New	+$41.9K	﹤0.01%	577

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Atom Investors's PGEN Position: Q1 2026 in Review

Atom Investors sold out of Precigen (PGEN) in Q1 2026, closing a stake of 61,825 shares — an estimated $258K sold.

Atom Investors first reported a position in PGEN in Q3 2025 and held it in 2 quarters. The position peaked at $258K in Q4 2025. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

Atom Investors reported no remaining Precigen position as of Q1 2026 after selling out during the quarter.
Atom Investors sold 61,825 Precigen shares in Q1 2026, an estimated $258K.
Atom Investors first reported a position in Precigen in Q3 2025 and held it in 2 quarters.
Atom Investors's Precigen position peaked at $258K in Q4 2025.
206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.